This company offers preclinical contract research services, specializing in metabolic disorders like obesity, diabetes, and hepatic fibrosis. They utilize both in vivo and in vitro models to evaluate drug efficacy and safety, providing comprehensive analyses for pharmaceutical, biotechnology, and nutraceutical clients.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical, biotechnology, and nutraceutical companies face challenges in efficiently and reliably evaluating the efficacy and safety of drug candidates for metabolic disorders. Traditional preclinical studies can be time-consuming and costly, hindering the development of new therapies for conditions like obesity, diabetes, and hepatic fibrosis.
Solution
Albor Biotech is a preclinical contract research organization (CRO) that specializes in providing tailored solutions for drug development, focusing on metabolic diseases and related complications. They offer comprehensive in vitro and in vivo services, including study design, model development, drug efficacy testing, and data analysis. Albor Biotech leverages over 15 years of expertise in metabolic diseases and behavioral mechanisms to deliver reliable preclinical studies targeting a spectrum of pathologies, such as obesity, diabetes, NASH/MASH fibrosis, inflammation, oxidative stress, and conditions influencing behavior. By offering specialized models and a range of tests, Albor Biotech assists clients in optimizing preclinical drug candidate studies, reducing both the cost and time to market for new therapies.
Target Audience
Albor Biotech primarily serves pharmaceutical, biotechnology, and nutraceutical companies, as well as research laboratories, that require preclinical research services to advance their drug development programs in the areas of metabolic disorders, oncology, and animal health.
Features
- In vivo services including body measurements, energy expenditure analysis via indirect calorimetry, and body composition analysis via nuclear magnetic resonance
- In vivo drug efficacy experiments for assessing energy homeostasis, glucose homeostasis (euglycemic, hyperglycemic, and hypoglycemic clamps; GTT, ITT, PTT, GlyTT, GSIS), and lipid metabolism
- Surgical services including catheter implantation, osmotic pump implantation, and stereotaxic surgery
- Biochemical and histological analysis, including ELISAs, enzymatic assays, Western blot analysis, real-time PCR, and RNAscope
- In vitro and ex vivo assays, including mitochondrial respiration analysis (Seahorse technology), lipid overload assays, cell sorting, and primary hepatocyte culture
- Diet- and chemical-induced obese and fibrotic models
- Behavioral tests to assess memory, stress, anxiety, learning, and motor skills
- Oncology services including xenograft experiments in immunodeficient mice, tumor growth assessment, and pharmacological efficacy studies
- Access to a scientific team with over 300 scientific publications